Randomised trial of lymphoblastoid α-interferon in chronic hepatitis C: Effects on inflammation, fibrogenesis and viremia
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 17 (3), 390-396
- https://doi.org/10.1016/s0168-8278(05)80223-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitisLiver International, 2008
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis: Relationship to liver histology and conventional liver testsJournal of Hepatology, 1991
- Therapy of chronic hepatitis C with α-interferon: The answer? Or more questions?Hepatology, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus AntibodiesScandinavian Journal of Infectious Diseases, 1989
- Colchicine in the Treatment of Cirrhosis of the LiverNew England Journal of Medicine, 1988
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986
- Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patientsDigestive Diseases and Sciences, 1986